Tag: Anticoagulants
Anticoagulation May Improve Outcomes in COVID-19 Patients
Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients
Thromboembolic Complications in COVID-19 Discussed
All hospitalized COVID-19 patients should be started on prophylactic low-molecular-weight heparin
Quality Improvement Effort Cuts Blood Clots in Brain Injury Patients
Prophylactic anticoagulation protocol improves patient outcomes
Rivaroxaban Prevents VTE After Lower-Limb Surgery
Rivaroxaban superior to enoxaparin for preventing major VTE after nonmajor orthopedic surgery
Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
Low-certainty evidence showed inconclusive effects for all-cause mortality, cardiovascular mortality, MI
Safety, Effectiveness of VKAs, DOACs Similar in General Practice
Risk for overall bleeding lower with vitamin K antagonists, but risk for mortality increased compared with DOACs
GI Bleeding in OAC-Treated A-Fib Patients Indicates CRC Risk
Lower-GI bleeding tied to high absolute risks for CRC in patients receiving oral anticoagulants for a-fib
Time of Day for Taking Warfarin Does Not Matter
Morning or evening administration makes no difference on time outside target INR range
Receipt of Anticoagulant Rx in ED Linked to Use at Six Months
Findings seen in patients aged 65 years or older with atrial fibrillation who present to emergency department
AHA: Risk for Death Cuts Benefit of Oral Anticoagulants for A-Fib
Findings seen among older patients with incident atrial fibrillation receiving warfarin or apixaban
